SCHEMBL17437460

SCHEMBL17437460

CCn1c(-n2ncnc2N)nc2cncc(-c3ccccc3F)c21

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RPS6KA5 O75582 2/20 0.34
SRC P12931 2/20 0.33
BTK Q06187 2/20 0.33
LYN P07948 1/20 0.33
TLR8 Q9NR97 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
HTT P42858 1/20 0.33
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
USP7 Q93009 1/20 0.32
PDE10A Q9Y233 1/20 0.32
ADORA2A P29274 1/20 0.31
EGLN2 Q96KS0 1/20 0.30
GUCY1A1 Q02108 1/20 0.30
GUCY1B1 Q02153 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2B Q13224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437352 0.93 DYRK1A (0.36) RPS6KA5GRIN1GRIN2B
SCHEMBL17437573 0.92 TLR8 (0.36) TLR8USP7ADORA2A
SCHEMBL16053847 0.89 RPS6KA5 (0.36) RPS6KA5SRCBTKLYNTLR8
SCHEMBL17437368 0.89 RPS6KA5 (0.39) RPS6KA5
SCHEMBL17437584 0.89 CYP3A4 (0.38) RPS6KA5TLR8CYP1A2CYP2D6
SCHEMBL17437538 0.88 CYP11B1 (0.34) RPS6KA5GRIN2B
SCHEMBL17437506 0.88 RPS6KA5 (0.34) RPS6KA5BTKLYNTLR8CYP1A2
SCHEMBL17437337 0.88 GRIN2B (0.33) RPS6KA5GRIN1GRIN2B
SCHEMBL17437576 0.88 HTR2C (0.35) RPS6KA5SRCTLR8CYP1A2CYP2D6
SCHEMBL17437395 0.88 DPP4 (0.36) RPS6KA5ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885SRC 3207/4885BTK 1073/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885SRC 3207/4885BTK 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.